BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10960464)

  • 1. Standardization of hepatitis C virus RNA quantification.
    Pawlotsky JM; Bouvier-Alias M; Hezode C; Darthuy F; Remire J; Dhumeaux D
    Hepatology; 2000 Sep; 32(3):654-9. PubMed ID: 10960464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.
    Martinot-Peignoux M; Boyer N; Le Breton V; Le Guludec G; Castelnau C; Akremi R; Marcellin P
    Hepatology; 2000 Mar; 31(3):726-9. PubMed ID: 10706564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
    Gourlain K; Soulier A; Pellegrin B; Bouvier-Alias M; Hézode C; Darthuy F; Rémiré J; Pawlotsky JM;
    J Clin Microbiol; 2005 Apr; 43(4):1669-73. PubMed ID: 15814982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
    Shiffman ML; Ferreira-Gonzalez A; Reddy KR; Sterling RK; Luketic VA; Stravitz RT; Sanyal AJ; Garrett CT; De Medina M; Schiff ER
    Am J Gastroenterol; 2003 May; 98(5):1159-66. PubMed ID: 12809843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ; Majewski DW; Yung B; Mitchell PS; Yao JD
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].
    Takenokuchi M; Yasuda C; Nakamachi Y; Mukai M; Yoon S; Kondoh S; Kumagai S
    Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA.
    Michelin BD; Muller Z; Stelzl E; Marth E; Kessler HH
    J Clin Virol; 2007 Feb; 38(2):96-100. PubMed ID: 17185031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
    Kinai E; Hanabusa H; Kato S
    J Med Virol; 2007 Aug; 79(8):1113-9. PubMed ID: 17596840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods.
    Forman MS; Valsamakis A
    J Clin Microbiol; 2004 Aug; 42(8):3581-8. PubMed ID: 15297501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells.
    Pugnale P; Latorre P; Rossi C; Crovatto K; Pazienza V; Gottardi AD; Negro F
    J Virol Methods; 2006 May; 133(2):195-204. PubMed ID: 16384611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of the LCx HCV RNA quantitative assay.
    Bertuzis R; Hardie A; Hottentraeger B; Izopet J; Jilg W; Kaesdorf B; Leckie G; Leete J; Perrin L; Qiu C; Ran I; Schneider G; Simmonds P; Robinson J
    J Virol Methods; 2005 Feb; 123(2):171-8. PubMed ID: 15620399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assay.
    Konnick EQ; Erali M; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2002 Mar; 40(3):768-73. PubMed ID: 11880391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0.
    Hsieh MY; Lee LP; Hou NJ; Yang JF; Huang JF; Dai CY; Chuang WL; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
    Kaohsiung J Med Sci; 2007 Jul; 23(7):332-8. PubMed ID: 17606427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.